Skip to content

5-MeO-DMT: all studies

Page 90 of 110: studies 891 to 900 of 1,096, newest first. Back to the 5-MeO-DMT overview

Research

Ayahuasca and cancer treatment

SAGE Open Medicine 2013 Eduardo E Schenberg 28 citations

Objectives: Comprehensively review the evidence regarding the use of ayahuasca, an Amerindian medicine traditionally used to treat many different illnesses and diseases, to treat some types of cancer. Methods: An in-depth review of the literature was conducted using PubMed, books, institutional magazines, conferences and online texts in nonprofessional sources regarding the biomedical knowledge...

Modification of Serial Pattern Learning by Designer Tryptamine Exposure during Adolescence: Comparison with Damage to the Dorsal Hippocampus or Prefrontal Cortex

December 1, 2012 D. Compton, Melissa C. Selinger, E. Westman et al.

Fo xy or Methoxy Fo xy (5-MeO-DIPT) is one of a series of new "club drugs" that within the past decade has gained in popularity among recreational users as an alternative to MDMA (Ecstasy). Unlike M DMA, not much is known about the neurobiological consequences of 5-MeO-DIPT use. Little is known about the effects of either co mpound on learning in a nonspatial appetitive task. In the present...

N-methylated tryptamine derivatives in citrus genus plants: identification of N,N,N-trimethyltryptamine in bergamot.

Journal of agricultural and food chemistry September 19, 2012 Luigi Servillo, Alfonso Giovane, Maria Luisa Balestrieri et al.

The occurrence of N-methylated tryptamine derivatives in bergamot plant (Citrus bergamia Risso et Poit) is reported for the first time. Interestingly, the most abundant of these substances is N,N,N-trimethyltryptamine, which has not been previously identified in any citrus plant. The N-methylated tryptamine derivatives were identified and quantitated in leaves, peel, juice, and seeds by...

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

PLoS One August 8, 2012 José Carlos Bouso, Débora González, Sabela Fondevila et al. 313 citations

Ayahuasca is an Amazonian psychoactive plant beverage containing the serotonergic 5-HT(2A) agonist N,N-dimethyltryptamine (DMT) and monoamine oxidase-inhibiting alkaloids (harmine, harmaline and tetrahydroharmine) that render it orally active. Ayahuasca ingestion is a central feature in several Brazilian syncretic churches that have expanded their activities to urban Brazil, Europe and North...

DOI: 10.1371/journal.pone.0042421 (opens in new tab) Ayahuasca Psychopathology Hallucinogen Impulsivity +2

Emerging psychoactive substance use among regular ecstasy users in Australia.

Drug and Alcohol Dependence July 1, 2012 Raimondo Bruno, Allison J Matthews, Matthew Dunn et al. 58 citations

The past decade has seen the development of an array of emerging psychoactive substances (EPS), however, there is minimal information on the extent of their use outside Europe. This study aimed to determine the extent of use of EPS from stimulant (such as mephedrone) and psychedelic classes (such as 5-methoxy-dimethyltryptamine [5-MeO-DMT]) among an Australian sample of regular ecstasy users...

Hypotheses Regarding the Mechanisms of Ayahuasca in the Treatment of Addictions

Journal of Psychoactive Drugs July 1, 2012 Mitchell B. Liester, James I. Prickett 78 citations

Ayahuasca is a medicinal plant mixture utilized by indigenous peoples throughout the Amazon River basin for healing purposes. The "vine of the soul" or "vine of death," as it is known in South America, contains a combination of monoamine oxidase inhibitors and N,N-dimethyltryptamine (DMT). When ingested together, these medicines produce profound alterations in consciousness. Increasingly,...

Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 10, 2012 Daniel I. Brierley, Colin Davidson 133 citations

Ayahuasca is a hallucinogenic botanical mixture originating in the Amazon area where it is used ritually, but is now being taken globally. The 2 main constituents of ayahuasca are N,N-dimethyltryptamine (DMT), a hallucinogen, and harmine, a monoamine oxidase inhibitor (MAOI) which attenuates the breakdown of DMT, which would otherwise be broken down very quickly after oral consumption. Recent...

Pharmacokinetic and pharmacodynamic interactions of indolealkylamine drugs of abuse

The FASEB Journal April 1, 2012 Ai-Ming Yu

Indolealkylamine (IAA) drugs are a major class of serotonin analogs that have high impact as substances of abuse. Among them, 5‐methoxy‐ N,N ‐dimethyltryptamine (5‐MeO‐DMT) was placed into Schedule I controlled substance status in the United States as of January 19, 2011, which is often co‐abused with harmaline. IAA drugs acts mainly on the serotonin neurotransmission system. Overdose of one...

DOI: 10.1096/fasebj.26.1_supplement.849.2 (opens in new tab) Serotonin Harmaline Pharmacology Monoamine oxidase +3

Electroencephalographic and convulsive effects of binge doses of (+)-methamphetamine, 5-methoxydiisopropyltryptamine, and (±)-3,4-methylenedioxymethamphetamine in rats.

The open neuropsychopharmacology journal 2012 Devon L Graham, Nicole R Herring, Tori L. Schaefer et al. 4 citations

The abuse of drugs such as methamphetamine (MA), 3,4-methylenedioxymethamphetamine (Ecstasy, MDMA), and 5-methoxydiisopropyltryptamine (5-MeO-DIPT; Foxy) is global. Symptoms from taking these drugs include tachycardia, agitation, hyperpyrexia, and sometimes seizures. We compared the EEG effects of these drugs in male Sprague-Dawley rats (~300 g) implanted with cortical electroencephalographic...

DOI: 10.2174/1876523801205010001 (opens in new tab) Full text (opens in new tab) MDMA Electroencephalographic activity Foxy Methamphetamine +1

Health status of ayahuasca users.

Drug Testing and Analysis 2012 Paulo César Ribeiro Barbosa, Suely Mizumoto, Michael P. Bogenschutz et al. 112 citations

Ayahuasca is a psychedelic brew originally used for magico-religious purposes by Amerindian populations of the western Amazon Basin. Throughout the last four decades, the use of ayahuasca spread towards major cities in all regions of Brazil and abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine- and harmala-alkaloid-containing tea may lead to mental and...

DOI: 10.1002/dta.1383 (opens in new tab) Full text (opens in new tab) Ayahuasca Traditional brew Psychedelic Plant medicine +14